V. Pechtner

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Guillermo E. Umpierrez, Federico Pérez Manghi, Linda Shurzinske et al. · Diabetes Care · 2014 · 337 citations

Medicine, Pharmacology, Pharmacotherapy +17

Treatment for 2 mo with n−3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study

Morvarid Kabir, Geraldine Skurnik, Nadia Naour et al. · American Journal of Clinical Nutrition · 2007 · 297 citations

Medicine, Nutrition, Nutritional Sciences +17

Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)

Francesco Giorgino, Marian Benroubi, Jui‐Hung Sun et al. · Diabetes Care · 2015 · 261 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Treatment for 2 mo with n−3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study

Morvarid Kabir, Geraldine Skurnik, Nadia Naour et al. · American Journal of Clinical Nutrition · 2007 · 117 citations

Medicine, Nutrition, Nutritional Sciences +17

Treatment satisfaction in people with type 2 diabetes mellitus treated with once‐weekly dulaglutide: data from the <scp>AWARD</scp> ‐1 and <scp>AWARD</scp> ‐3 clinical trials

Matthew Reaney, Miao Yu, Mark Lakshmanan et al. · Diabetes Obesity and Metabolism · 2015 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +17